Stoke Therapeutics, Inc.

NASDAQ:STOK

Biotechnology

Healthcare
$26.93 -1.12%

-$0.34 today

Market cap
$1.76B
Beta
1.19
P/E (TTM)
-11.1
EPS (TTM)
-$2.69
52W Low $11.17High $40.22

Volume 0.64M

Average 0.64M

Balance Sheet

Inspect the capital base behind the business.

Assets

$418.43M

FY 2025 · Annual

+54.1% YoY

Liabilities

$65.98M

FY 2025 · Annual

+55.1% YoY

Equity

$352.46M

FY 2025 · Annual

+53.9% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents144.9M113.56M191.44M127.98M84.22M
Short-term Investments74.92M116.04M9.95M88.92M200.45M
Net Receivables132K588K64K700K7.91M
Inventory00000
Other Current Assets2.33M2.96M2.56M4.04M4.39M
Total Current Assets229.22M244.07M215.34M232.76M305.7M
Property, Plant & Equipment (Net)9.08M11.43M12.43M8.25M6.25M
Goodwill00000
Intangible Assets00000
Long-term Investments00029.82M0
Tax Assets00000
Other Non-current Assets569K569K569K721K106.49M
Total Non-current Assets9.65M12M13M38.8M112.73M
Total Assets238.87M256.07M228.34M271.56M418.43M
Account Payables2.39M766K1.7M2.5M4.94M
Short-term Debt00000
Tax Payables00000
Deferred Revenue014.88M15.31M18.99M11.9M
Other Current Liabilities5.92M6.26M6.47M8.44M15.04M
Total Current Liabilities17.14M31.39M30.82M40.06M57.88M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)036.86M33.07M06.96M
Other Non-current Liabilities3.95M2.97M4.88M2.48M1.14M
Total Non-current Liabilities3.95M39.82M37.96M2.48M8.1M
Total Liabilities21.09M71.22M68.78M42.53M65.98M
Common Stock4K4K5K5K5K
Retained Earnings(196.08M)(297.15M)(401.85M)(490.83M)(497.72M)
Accumulated OCI(168K)(1.18M)(24K)(151K)543K
Other Stockholders Equity00000
Minority Interest00000
Total Equity217.78M184.85M159.57M229.02M352.46M
Total Debt1.51M2.36M2.06M2.32M3.01M
Net Debt(143.39M)(111.2M)(189.38M)(125.66M)(81.21M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$155.7M
Short-term Investments$187.9M
Receivables$6.1M
Other Current$17.0M
Total Current Assets$366.7M
PP&E (Net)$5.9M
Long-term Investments$67.5M
Other Non-current$3.2M
Total Non-current Assets$76.6M
Total Assets$443.3M

Analysis

Selected assets total $443.3M for Latest. The largest visible component is Short-term Investments at $187.9M, about 42.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
10-QQuarterly reportNov 3, 2026
8-KCurrent reportOct 29, 2026

How much cash does STOK have?

Stoke Therapeutics, Inc. (STOK) reported $84.22M in cash and equivalents in fiscal 2025.

How much debt does STOK carry?

Stoke Therapeutics, Inc. (STOK) reported $3.01M of total debt, with net debt of -$81.21M.